FDA issues compounding risk alerts to communicate information to alert health care professionals to adverse events and outbreaks related to compounded drugs so that practitioners can more effectively protect patients from unsafe, ineffective, and poor quality compounded medicines.

Source: FDA

Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Medline; the same agency is already in play for this signal, so precedent weight is higher.

Source: FDA

Food and Drug Administration (FDA) is investigating the safety of sevoflurane and other general anesthetics based on published scientific reports of unexpected catastrophic outcomes, including severe neurologic adverse outcomes and death, occurring in adult and pediatric patients.

Source: FDA

Medline is correcting affected convenience kits by removing recalled Bupivacaine Hydrochloride in Dextrose Injection components.

Source: FDA

Certain BD ChloraPrep Applicators in Convenience Kits manufactured by Medline may not be sterile.

Source: FDA

FOR IMMEDIATE RELEASE – June 11, 2026, Covina, CA - Beekeeper’s Naturals is voluntarily recalling lot # 5950, Exp. Date 02/2028 of Beekeeper’s Naturals Saline Nasal Spray, sold only through Amazon, to the consumer level.

Source: FDA

The recall of Hibiwash due to microbial contamination poses significant risks to Mölnlycke Health Care's reputation and market position. This incident highlights the need for stringent quality control measures and proactive communication strategies to maintain trust with healthcare providers and consumers. Regulatory context from FDA (NARA ORGANICS RECALLS ALL LOTS OF NARA INFANT FORMULA BECAUSE OF POSSIBLE HEALTH RISK) supports the near-term read. Assessment grounded in 22 ranked evidence items (9 high-relevance).

Source: Humanexa Insight